Home › Alopecia Areata › Ohio
Alopecia Areata clinical trials in Ohio
6 studies for Alopecia Areata are looking for participants at sites in Ohio.
Cities in Ohio
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Bexley Dermatology Research, Bexley
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 18, 2026 · NCT06873945A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
- Dermatologists of Southwestern Ohio (DSWO) /ID# 282818, Fairborn
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 17, 2026 · NCT07772492HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
- The Ohio State University Wexner Medical Center, Columbus
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Sep 15, 2026 · NCT07049328A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- Bexley Dermatology Research, Bexley
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 10, 2026 · NCT07733765A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Cleveland Clinic - Cleveland /ID# 258113, Cleveland
- Dermatologists of Southwest Ohio, Inc /ID# 260116, Mason
RecruitingPhase 3
Ages 12 to 63 · All sexes · Updated Aug 3, 2026 · NCT06012240Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- Dermatologists Of Southwest Ohio, Mason
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Jan 28, 2026 · NCT07133308From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.